This recombinant Pseudomonas mendocina protein is a probable protein kinase regulator of UbiI activity, involved in aerobic coenzyme Q (ubiquinone) biosynthesis.
KEGG: pmy:Pmen_0521
STRING: 399739.Pmen_0521
Pseudomonas mendocina is a Gram-negative, aerobic, rod-shaped bacterium belonging to the Pseudomonadaceae family, naturally found in water and soil samples. First discovered in 1969, it has gained research interest due to its metabolic versatility and unique biosynthetic pathways . P. mendocina serves as an important model organism for studying ubiquinone biosynthesis, particularly through the UbiB protein, which plays a crucial role in the aerobic hydroxylation steps of ubiquinone production. This bacterium's relatively rare occurrence in human infections (with only 14 documented cases worldwide as of 2019) makes it an interesting subject for both environmental microbiology and specialized clinical research .
The recombinant P. mendocina UbiB protein (UniProt accession: A4XPM5) is a full-length protein consisting of 527 amino acids. Its complete sequence begins with MKLLAVRRLLRIQRVVIRY and continues through to LVGGGLYLVLRR at the C-terminus . The protein contains multiple functional domains characteristic of ubiquinone biosynthesis proteins, including kinase-like domains that are essential for its activity. When produced as a recombinant protein, it is typically stored in a Tris-based buffer with 50% glycerol for stability and maintained at -20°C for standard storage or -80°C for extended preservation . The tertiary structure features catalytic sites involved in the hydroxylation reactions necessary for ubiquinone synthesis.
UbiB is a probable ubiquinone biosynthesis protein that functions as part of the aerobic ubiquinone (UQ) biosynthetic pathway. While its exact biochemical function is still being elucidated, research suggests it plays a role similar to that of kinase-like proteins in the ubiquinone biosynthetic pathway. UbiB likely participates in the hydroxylation steps required for the conversion of early precursors into functional ubiquinone, which serves as the major electron carrier in the reduction of oxygen during aerobic respiration .
In P. aeruginosa and related Pseudomonas species, ubiquinone (specifically UQ9 - ubiquinone with nine isoprenoid units) has been identified as the predominant quinone essential for growth during anaerobic respiration, particularly during denitrification processes . By extension, UbiB in P. mendocina likely plays a similar critical role in the synthesis of ubiquinone molecules necessary for both aerobic and possibly anaerobic respiratory mechanisms.
Based on established protocols for similar Pseudomonas recombinant proteins, optimal expression of P. mendocina UbiB can be achieved using the following methodological approach:
Expression System Selection:
E. coli BL21(DE3) or Rosetta(DE3) strains typically yield high expression levels for Pseudomonas proteins
pET-based vectors containing T7 promoters provide controlled, high-yield expression
Culture Conditions:
Initial growth at 37°C to OD600 of 0.6-0.8
Temperature reduction to 18-25°C before induction to enhance soluble protein production
Induction with 0.1-0.5 mM IPTG for 16-20 hours
Expression Optimization Table:
| Parameter | Standard Condition | Optimization Range | Notes |
|---|---|---|---|
| Growth temperature | 37°C | 30-37°C | Higher temperatures increase growth rate |
| Induction temperature | 18°C | 16-25°C | Lower temperatures reduce inclusion body formation |
| IPTG concentration | 0.2 mM | 0.1-1.0 mM | Excessive IPTG can lead to toxicity |
| Post-induction time | 18 hours | 4-24 hours | Longer times may increase yield but risk degradation |
| Media composition | LB | LB, TB, 2×YT | Rich media (TB) increases biomass but may affect folding |
The addition of 0.5-1% glucose during the growth phase can help reduce basal expression leakage, while supplementation with iron compounds (50-100 μM FeSO4) may improve the incorporation of potential iron-sulfur clusters if present in the native protein structure.
Purification of active recombinant UbiB requires a multi-step approach that preserves the protein's catalytic capabilities:
Primary Purification:
Cell lysis using sonication or pressure-based systems in a buffer containing 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, and 1 mM DTT
Initial purification via Immobilized Metal Affinity Chromatography (IMAC) if the recombinant protein contains a histidine tag
Secondary purification using ion exchange chromatography (typically Q-Sepharose)
Final polishing step using size exclusion chromatography
Critical Considerations:
Inclusion of reducing agents (1-5 mM DTT or 2-10 mM β-mercaptoethanol) throughout purification to prevent oxidation of critical cysteine residues
Addition of glycerol (10-20%) to stabilize the protein structure during purification and storage
Potential requirement for specific cofactors (such as flavin or iron) to maintain the protein's functional state
Activity Preservation Method:
Store purified UbiB in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 50% glycerol, 1 mM DTT at -20°C for routine use, or aliquot and store at -80°C for long-term preservation . Avoid repeated freeze-thaw cycles as this significantly reduces enzymatic activity.
Functional assessment of UbiB activity can be performed through several complementary approaches:
In vitro Enzymatic Assays:
Kinase-like Activity Assay: Monitor ATP consumption using luciferase-based ATP detection systems or radioactive [γ-32P]ATP
Hydroxylation Activity Assay: Measure the conversion of isotopically labeled substrates to hydroxylated products using HPLC-MS/MS
Complementation Studies:
Transform UbiB-deficient bacterial strains with plasmids expressing the recombinant P. mendocina UbiB
Assess restoration of ubiquinone biosynthesis through:
Growth under conditions requiring respiratory chain function
Direct measurement of ubiquinone levels using HPLC analysis
Protein-Protein Interaction Studies:
Use pull-down assays, bacterial two-hybrid systems, or surface plasmon resonance to identify interactions with other ubiquinone biosynthesis pathway components
Cross-validation with co-immunoprecipitation using antibodies against native interaction partners
These methods provide complementary information about both the catalytic activity and biological significance of the purified UbiB protein.
Recent research has revealed that ubiquinone biosynthesis in Pseudomonas species involves distinct pathways under aerobic and anaerobic conditions, with potential implications for UbiB function:
In related bacteria like E. coli, the UbiU, UbiV, and UbiT proteins form a complex essential for anaerobic ubiquinone biosynthesis . Homologs of these genes have been identified in P. aeruginosa (PA3911, PA3912, and PA3913), suggesting a similar mechanism may exist in Pseudomonas species.
While UbiB's precise role in these distinct pathways is still being elucidated, the protein likely functions differently depending on oxygen availability:
Comparative Function Analysis:
| Condition | Proposed UbiB Function | Associated Pathway Components | Regulatory Mechanisms |
|---|---|---|---|
| Aerobic | Oxygen-dependent hydroxylation step mediator | Classical UQ biosynthesis enzymes | Transcriptional regulation by oxygen-sensing factors |
| Anaerobic | Potential interaction with UbiU/UbiV/UbiT complex | Alternative hydroxylation machinery | Possibly regulated by anaerobic response elements |
Research methodologies to investigate these differences should include comparative proteomics under aerobic versus anaerobic conditions, metabolic flux analysis of ubiquinone intermediates, and protein interaction studies specific to each condition.
An intriguing area of research involves the potential interplay between ubiquinone biosynthesis and light-responsive gene regulation in P. mendocina. Studies have identified that P. mendocina contains a blue light-responsive system involving PmlR2 (a class II LitR/CarH family transcriptional regulator) and PmSB-LOV (a "short" LOV-type blue light photoreceptor) .
When exposed to blue light, PmSB-LOV undergoes a conformational change that allows it to directly associate with PmlR2, inhibiting the DNA-binding ability of PmlR2 . This inhibition enables RNA polymerase to access and transcribe light-inducible genes.
While the direct relationship between this light-sensing system and ubiquinone biosynthesis has not been fully established, several hypothetical connections exist:
Ubiquinone's role as an electron carrier in photosynthetic bacteria suggests possible regulatory connections between light perception and electron transport chain components
The redox state influenced by ubiquinone may serve as a feedback mechanism for light-responsive gene regulation
Both systems may be co-regulated as part of the bacterium's adaptation to environmental conditions
Methodological approach to investigate this relationship:
Transcriptomic analysis comparing wild-type and UbiB-deficient strains under different light conditions
Metabolomic profiling of ubiquinone levels in response to light exposure
Chromatin immunoprecipitation sequencing (ChIP-seq) to identify potential binding sites of PmlR2 near ubiquinone biosynthesis genes
Construction of reporter gene fusions to monitor expression of UbiB and other ubiquinone biosynthesis genes under varying light conditions
Advanced structural biology methods offer powerful tools for elucidating UbiB's functional mechanisms:
X-ray Crystallography and Cryo-EM:
Determining the high-resolution structure of UbiB would reveal critical insights into its catalytic mechanism, substrate binding sites, and potential interaction surfaces. Researchers should consider the following methodological approaches:
Protein engineering to improve crystallization properties:
Surface entropy reduction
Truncation of disordered regions
Incorporation of crystallization chaperones
Co-crystallization with:
Substrate analogs
ATP or other potential cofactors
Interaction partners from the ubiquinone biosynthesis pathway
Molecular Dynamics Simulations:
Following structural determination, molecular dynamics simulations can predict:
Conformational changes during catalysis
Substrate access routes
Effects of mutations on protein stability and function
Integrative Structural Biology Approach:
Combine multiple methods for a comprehensive understanding:
These structural insights would guide the design of targeted mutations to test mechanistic hypotheses and potentially enable the development of specific inhibitors or activators of UbiB function.
Comparative analysis of UbiB across bacterial species reveals evolutionary adaptations and functional conservation:
The UbiB protein belongs to a conserved family of proteins involved in ubiquinone biosynthesis across diverse bacterial species. In P. mendocina, UbiB (encoded by the ubiB gene, locus Pmen_0521) shares significant sequence and functional similarity with homologs in other bacteria .
Comparative Analysis Table:
| Species | Protein Identity to P. mendocina UbiB | Key Structural Differences | Functional Implications |
|---|---|---|---|
| E. coli | ~60-70% | Extended N-terminal region | Potentially different regulation |
| P. aeruginosa | ~85-90% | High conservation in catalytic domains | Similar catalytic mechanism |
| P. stutzeri | ~80-85% | Similar domain organization | Likely functional equivalence |
| Non-Pseudomonas proteobacteria | ~50-60% | Variable loop regions | Adapted to different substrate specificities |
Research methodologies to explore these differences should include:
Phylogenetic analysis: Construct comprehensive phylogenetic trees of UbiB proteins to trace evolutionary relationships and identify potential horizontal gene transfer events
Domain swapping experiments: Create chimeric proteins with domains from different species to map functional regions
Heterologous complementation tests: Express P. mendocina UbiB in other bacterial species with UbiB deletions to assess functional conservation
This comparative approach provides insights into both the core conserved functions of UbiB and species-specific adaptations that may relate to different ecological niches or metabolic requirements.
Understanding and manipulating UbiB offers several promising biotechnological applications:
Bioprocess Engineering:
Enhanced ubiquinone (CoQ10) production: Engineered overexpression of UbiB and other pathway components could increase ubiquinone yields for commercial production
Bioremediation applications: P. mendocina strains with modified UbiB could potentially enhance degradation of recalcitrant environmental pollutants through improved electron transport capabilities
Pharmaceutical Research:
Antimicrobial drug development: UbiB represents a potential target for novel antibiotics against Pseudomonas infections, which is particularly relevant given P. mendocina's documented role in human infections
Development of inhibitor screening platforms: Recombinant UbiB could be used to develop high-throughput screening systems to identify novel inhibitors of bacterial ubiquinone biosynthesis
Synthetic Biology:
Creation of artificial electron transport chains: Engineered UbiB variants could potentially enable the design of synthetic electron transport systems with novel properties
Biosensor development: UbiB-based biosensors could potentially detect specific metabolites or environmental conditions by coupling ubiquinone biosynthesis to reporter systems
The development of these applications would require comprehensive understanding of UbiB's structure-function relationships, catalytic mechanisms, and regulatory networks.
Several methodological advances would significantly enhance our understanding of UbiB function:
Technical Innovations Needed:
Improved in vitro reconstitution systems:
Development of membrane-mimetic systems that better recapitulate the native environment of UbiB
Establishment of coupled enzyme assays to monitor UbiB activity in real-time
Advanced imaging techniques:
Super-resolution microscopy to visualize UbiB localization and dynamics in living cells
Correlative light and electron microscopy to connect UbiB localization with membrane ultrastructure
Genetic tools for P. mendocina:
CRISPR-Cas9 based genome editing systems optimized for P. mendocina
Inducible promoter systems for controlled gene expression
Transposon mutagenesis libraries for high-throughput functional screening
Metabolic flux analysis:
Isotope-labeled precursor studies to trace ubiquinone biosynthesis flux
Integration with computational models of bacterial metabolism
Research Priority Matrix:
| Knowledge Gap | Technical Approach | Expected Impact |
|---|---|---|
| Precise catalytic mechanism | Structural studies combined with directed mutagenesis | Enable rational design of UbiB variants with enhanced activity |
| Protein interaction network | Proximity labeling proteomics (BioID, APEX) | Identify previously unknown functional connections |
| In vivo dynamics | Fluorescent protein fusions with super-resolution imaging | Understand spatial and temporal regulation |
| Metabolic integration | Systems biology approaches with multi-omics integration | Reveal how UbiB function coordinates with broader cellular metabolism |
Addressing these knowledge gaps through methodological innovations would significantly advance our understanding of UbiB function and expand its potential biotechnological applications.